Correlation Between Opthea and Exagen
Can any of the company-specific risk be diversified away by investing in both Opthea and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Exagen Inc, you can compare the effects of market volatilities on Opthea and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Exagen.
Diversification Opportunities for Opthea and Exagen
Significant diversification
The 3 months correlation between Opthea and Exagen is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Opthea i.e., Opthea and Exagen go up and down completely randomly.
Pair Corralation between Opthea and Exagen
Considering the 90-day investment horizon Opthea is expected to generate 0.48 times more return on investment than Exagen. However, Opthea is 2.09 times less risky than Exagen. It trades about 0.14 of its potential returns per unit of risk. Exagen Inc is currently generating about 0.01 per unit of risk. If you would invest 369.00 in Opthea on November 28, 2024 and sell it today you would earn a total of 121.00 from holding Opthea or generate 32.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Opthea vs. Exagen Inc
Performance |
Timeline |
Opthea |
Exagen Inc |
Opthea and Exagen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Opthea and Exagen
The main advantage of trading using opposite Opthea and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.Opthea vs. Beam Therapeutics | Opthea vs. Editas Medicine | Opthea vs. Caribou Biosciences | Opthea vs. Verve Therapeutics |
Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
CEOs Directory Screen CEOs from public companies around the world | |
Stocks Directory Find actively traded stocks across global markets |